非酒精性脂肪性肝病合并HBV感染患者临床特征分析

doi:10.3969/j.issn.1672-5069.2015.05.024

Abstract

Liu Sufen，Wu Borong，Liu Zhenzhong，et al.. Clinic characteristics of patients with chronic hepatitis B overlapped with non-alcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 540-541.

References

[1] 刘晓，朱月永. 慢性乙型肝炎合并非酒精性脂肪肝的研究进展. 实用肝脏病杂志，2009，12（4）:318-320.
[2] 黄小忠，易芳. 48例非酒精性脂肪肝合并慢性乙型肝炎患者临床分析. 中国当代医药，2012，19（24）:13-15.
[3] 李红山，朱德东，李德周，等. 慢性乙型肝炎合并非酒精性脂肪肝患者机体免疫功能的变化. 中国卫生检验杂志，2013， 23（6）:1499-1501.
[4] 彭仙娥. 乙型肝炎病毒在非酒精脂肪肝发生中的作用及机制研究.福建医科大学，2009，21（2）:145-147.
[5] 贾继东，李兰娟. 慢性乙型肝炎防治指南（2010年版）. 中国内科学杂志，2011，50（2）:168-179.
[6] 范建高. 中国非酒精性脂肪性肝病诊疗指南（2010年修订版）. 中国医学前沿杂志（电子版）， 2012，4（7）:4-10.
[7] 中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南（节录）. 营养学报，2004，26（1）:1-4.
[8] 郑瑞丹. 慢性乙型肝炎合并非酒精性脂肪性肝病患者体质量指数与血脂水平的研究. 肝脏，2012，17（4）:247-249.
[9] 赵莹，邵清，陈国凤. 慢性乙型肝炎合并非酒精性脂肪肝的研究动态. 传染病信息，2013，26（5）:315-318.
[10] 施军平，过建春，刘雁，等. 慢性乙型肝炎合并非酒精性脂肪性肝病75例临床和病理分析. 临床医学，2006，26（11）:4-6.
[11] 魏月芳，范永利，刘娇玲. 非酒精性脂肪肝危险因素分析及预防. 长治医学院学报，2010，24（4）:265-267.
[12] 郭万越. 非酒精性脂肪肝相关因素Logistic回归分析. 实用肝脏病杂志，2011，14（5）:376-378.
[13] 陈文玉，殷晓勇，孙桂菊，等. 362名脂肪肝患者相关指标及相关疾病患病状况研究. 东南大学学报:医学版，2004，23（6）:397-400.

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[3]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[4]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[5]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
[6]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[7]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[8]	Wang Baodan, Li Meng, Gao Yu. Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
[9]	Fu Liang, Wu Dongbing, Ji Xinzun. Application of ARFI quantification in the evaluation of liver injuries in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 377-380.
[10]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[11]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[12]	Su Shuting, Zhong Yan, Mi Yuqiang.. Management of patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 293-296.
[13]	Zhang Feng, Yan Yan.. Implication of serum apolipoprotein B levels and its correlation with metabolic syndrome in checked-up individuals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 61-64.
[14]	Song Na, Liu Xiaoyan, Liu Chang, et al.. Changes of plasma thyrotropin levels in patients with nonalcoholic fatty liver disease and type 2 diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 65-68.
[15]	Cui Qinghua, Tao Hong, Wang Xiaoyue, et al.. Changes of serum glycosylated hemoglobin level and cardiac functions in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 69-72.

Clinic characteristics of patients with chronic hepatitis B overlapped with non-alcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments